Advertisement
Home Tags Cancer: Laryngeal

Tag: Cancer: Laryngeal

An artificial larynx has provided long-term relief for a throat cancer patient in France who had a total laryngectomy

Artificial Larynx Implant Feasible After Total Laryngectomy

0
New device has improved long-term quality of life in patient with total laryngectomy
Patients with sustained or newly developed cancer cachexia at six and 12 months after initial treatment for advanced head and neck squamous cell carcinoma are at higher risk of cancer recurrences

Cancer Cachexia Associated With Poor Outcomes

0
Findings at six and 12 months after treatment for advanced head and neck cancer
For patients with head and neck cancer receiving radiotherapy

Radiation Dose to Head & Neck Tied to Thyroid Dysfunction Risk

0
Findings in patients with head and neck cancer receiving RT; female sex, concurrent chemo up risk
For nonmetastatic nasopharyngeal carcinoma

Adjuvant Chemo Plus CRT Best in Nasopharyngeal Carcinoma

0
Highest survival benefit for addition of AC to CRT, with consistent improvement for all end points
For patients with squamous cell carcinoma

Microsurgical Head and Neck Reconstruction Is Cost-Effective

0
Cost-effective versus locoregional flaps for all stages of SCC, especially in early-stage cancer
For patients with laryngeal squamous cell carcinoma

Type of Treatment Impacts Recurrence in Laryngeal SCC

0
WHO performance status >0, neck metastasis, nonsurgical treatment predict recurrence
A stepped care program is likely to be cost-effective for patients with head and neck cancer or lung cancer who have psychological distress

Stepped Care Likely to Be Cost-Effective in Head & Neck, Lung CA

0
Mean costs lower and mean number of quality-adjusted life-years higher in intervention group
Patients with multiple areas of dysplastic squamous epithelium have increased risk for metachronous squamous cell carcinomas in the upper aerodigestive tract

Multiple Dysplastic Lesions in Esophagus Up Risk of SCC

0
Increased risk of multiple squamous cell carcinomas in esophagus and head and neck
Nivolumab is associated with longer overall survival than standard single-agent therapy in patients with platinum-refractory

Nivolumab Ups Overall Survival in Head, Neck Cancer

0
Longer overall survival compared with single-agent therapy for platinum-refractory squamous-cell cancer
For patients with head and neck cancer

Shorter Duration of Feeding Tube Placement With IMRT

0
Findings among patients with head and neck cancer undergoing definitive intensity modulated RT